UAE
Bahrain
Jordan
Kuwait
Oman
Qatar
Saudi ArabiaHealth News
Suicide in apparently well-functioning young men
Date: Feb-27-2014Suicide among young men is a major public health concern in many countries, despite great efforts to find effective prevention strategies. By interviewing close relatives and friends of apparently well-functioning young men who unexpectedly took their own life, Norwegian researchers found there had been no signs of serious mental disorder. This contradicts previous research which suggests that depression or other mental illness is an important risk factor in suicide.
New research could signal progress in osteoarthritis pain relief
Date: Feb-27-2014Researchers from the Arthritis Research UK Pain Centre at The University of Nottingham have discovered a new way to potentially block the chronic and often debilitating pain affecting osteoarthritis sufferers.Currently, people experiencing the severe pain associated with OA are offered pain relieving drugs such as steroid injections and non-steroidal anti-inflammatory drugs, which work by reducing inflammation. However, some of these drugs can be associated with severe side-effects that limit their use.
Sunburns strike twice
Date: Feb-27-2014Melanoma is particularly dangerous because it can form metastases in vital organs such as the lungs, liver or brain. UV radiation is considered to be the most significant triggering factor. An interdisciplinary team of researchers from the University Hospital and the LIMES Institute of the University of Bonn has now discovered that sunburns contribute to the development of this malignant disease not only through direct alteration of pigment cell genomes but also indirectly through inflammatory processes in the surrounding tissue.
Sunburns strike twice
Date: Feb-27-2014Melanoma is particularly dangerous because it can form metastases in vital organs such as the lungs, liver or brain. UV radiation is considered to be the most significant triggering factor. An interdisciplinary team of researchers from the University Hospital and the LIMES Institute of the University of Bonn has now discovered that sunburns contribute to the development of this malignant disease not only through direct alteration of pigment cell genomes but also indirectly through inflammatory processes in the surrounding tissue.
New research to revolutionise healthcare through remote monitoring of patients
Date: Feb-27-2014Researchers from the University of Surrey have launched a new programme of research called eSMART (Electronic Symptom Management using ASyMS Remote Technology), that uses mobile phone technology to remotely monitor patients who are undergoing chemotherapy to treat breast, bowel and blood cancers.The Advanced Symptom Management System (ASyMS) allows patients to report the side effects from their chemotherapy via a mobile phone.
Mirvaso® (brimonidine) the first and only treatment targeting the facial redness of rosacea approved by the European Commission
Date: Feb-27-2014Galderma, a leading global pharmaceutical company exclusively focused on dermatology, today announced that the European Commission has granted Marketing Authorisation in Europe for Mirvaso® (brimonidine) 3 mg/g gel.Mirvaso® is an alpha-2 adrenergic receptor agonist that acts rapidly and can last for up to 12 hours.1 It is indicated for the symptomatic treatment of facial erythema (redness) of rosacea in adult patients."Mirvaso® is the only approved medicinal product that directly targets the facial redness of rosacea and provides an innovative therapy for the condition.
Self-rated physical fitness in midlife an indicator of dementia risk
Date: Feb-27-2014How would you rate your own physical fitness? Is it good, satisfactory or maybe even poor? Surprisingly, your answer may reveal your future risk of getting dementia.A recent collaborative study from Finland, involving the follow-up of 3,559 adults for 30 years, has found that a simple question about self-rated physical fitness in midlife may reveal individuals who are at an increased risk of developing dementia.
Mirvaso® (brimonidine) the first and only treatment targeting the facial redness of rosacea approved by the European Commission
Date: Feb-27-2014Galderma, a leading global pharmaceutical company exclusively focused on dermatology, today announced that the European Commission has granted Marketing Authorisation in Europe for Mirvaso® (brimonidine) 3 mg/g gel.Mirvaso® is an alpha-2 adrenergic receptor agonist that acts rapidly and can last for up to 12 hours.1 It is indicated for the symptomatic treatment of facial erythema (redness) of rosacea in adult patients."Mirvaso® is the only approved medicinal product that directly targets the facial redness of rosacea and provides an innovative therapy for the condition.
Music as therapeutic intervention can relieve anxiety and depression in older people
Date: Feb-27-2014Using music and singing in health care can improve quality of life for older people by easing pain, anxiety and depression.According to an article published in Mental Health Practice, the practices can be easily and effectively used as therapeutic nursing interventions.A literature review of articles related to anxiety and the use of music as a therapy for people over the age of 65 found it has a positive influence on wellbeing by providing enjoyment, social interaction, improved memory and social inclusion.
Female Genital Mutilation is child abuse and should be dealt with as a safeguarding issue, say UK GPs
Date: Feb-27-2014GPs who suspect that a child has been subjected to Female Genital Mutilation should refer the parent or guardian to social services, says the Royal College of General Practitioners. In its written evidence to the Home Office Select Committee released today, the RCGP describes FGM as 'child abuse' and calls for it to be treated as a safeguarding issue. However, the College also raises concerns about the capacity of social services to respond to referrals and is calling for a multi-agency approach to better support the young girls and women affected.
Stay Connected
